<DOC>
	<DOCNO>NCT00524160</DOCNO>
	<brief_summary>The purpose study assess degree pain control achieve treatment fentanyl , administer via adhesive patch apply skin ( 'transdermal system '' ) patient rheumatoid arthritis osteoarthritis knee hip . Treatment administer fo r4 week , add exist therapy medication .</brief_summary>
	<brief_title>A Study Effect Pain Control Treatment With Fentanyl , Administered Through Skin , Patients With Rheumatoid Arthritis Osteoarthritis</brief_title>
	<detailed_description>Chronic , non-cancer pain may result injury illness , rheumatoid arthritis osteoarthritis , cause suffer reduction quality life . Opioids , fentanyl , beneficial potent pain-relieving drug patient continuous pain . This open-label , prospective study ass degree pain control provide treatment fentanyl administer skin via adhesive patch ( `` transdermal system '' ) 28 day patient rheumatoid arthritis osteoarthritis hip knee , whose pain inadequately control medication . During first week treatment , prophylactic anti-nausea vomit agent give patient control symptoms occur opioid therapy . After 28 day , patient respond adequately treatment taper gradually reduce dose fentanyl . Assessment effectiveness include rating pain control ( excellent , good , moderate , poor , poor ) , Pain Assessment Questionnaire , Quality Life Questionnaire ( SF-36 ) , Health Assessment Questionnaire ( HAQ ) , record usage additional pain-relieving medication , evaluation anti-nausea vomit treatment . Safety evaluation include incidence adverse event , physical examination . The study hypothesis patient rheumatoid arthritis osteoarthritis hip knee whose pain adequately control medication show improvement pain control 28 day treatment fentanyl transdermal system . Fentanyl transdermal patch deliver 25 micrograms/hr 100 micrograms/hr , change every 3 day , 28 day ; dos may adjust adequate pain control , Anti-nausea tablet ( Metoclopramide , 10 mg , 3 times/day ) first week . Paracetamol tablet ( 500mg ) supplement pain control .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patients must meet American College Rheumatology criterion rheumatoid arthritis ( RA ) osteoarthritis ( OA ) hip knee moderate severe pain adequately control medication ( paracetamol ( acetaminophen ) , NSAIDs , COX2 inhibitor , weak opioids ) OA patient must need wait hip knee replacement RA patient use disease modify antirheumatic drug ( DMARDs ) must stable dose medication &gt; =3 month . Patients receive regular treatment strong opioids month prior study another continuous pain stand compare RA OA pain skin disease know allergy hypersensitivity fentanyl adhesives history liver disease new physical therapy change therapy within one month study pregnant nursing female , without adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Fentanyl</keyword>
	<keyword>opioid analgesic</keyword>
	<keyword>arthritis</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>transdermal administration</keyword>
</DOC>